Vaccines

21 May 2020 IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
21 May 2020 CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
21 May 2020 AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
20 May 2020 Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
20 May 2020 INOVIO’s COVID-19 DNA vaccine INO-4800 demonstrates robust neutralizing antibody and T cell immune responses in preclinical models
19 May 2020 PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
19 May 2020 Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
18 May 2020 GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines
18 May 2020 Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
15 May 2020 Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19
14 May 2020 INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
14 May 2020 Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
14 May 2020 CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
14 May 2020 VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual
12 May 2020 Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
11 May 2020 TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection
08 May 2020 ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19
06 May 2020 Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
06 May 2020 OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
06 May 2020 CEPI seeks to expand COVID-19 vaccine portfolio, focusing on speed and global manufacturing
05 May 2020 Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
04 May 2020 Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
04 May 2020 Stallergenes Greer Submits a Marketing Authorisation Application in Europe for Its Sublingual House Dust Mite Allergen Immunotherapy Tablet
01 May 2020 Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
30 Apr 2020 INOVIO expands manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top